Free software on your phone or tablet lets you scan, create, edit, annotate and even sign digitized documents on the go. By J. D. Biersdorfer I write the monthly Tech Tip column, which is devoted to ...
TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, ...
A dietary supplement meant to support normal bladder control has been recalled because it may be contaminated with bacteria. Purity Products has recalled MyBladder due to potential contamination with ...
The FDA has prioritized reviewing Padcev and Keytruda for MIBC patients ineligible for cisplatin chemotherapy, with a target action date of April 7, 2026. Phase 3 EV-303 trial results showed a 60% ...
Fran Curtis experienced mild urinary changes, leading to a bladder cancer diagnosis, highlighting the importance of early detection in women. Initial BCG treatment was unsuccessful, prompting a second ...
In 2025, approximately 85,000 patients will be diagnosed with bladder cancer. 1 Of these, approximately 80% are non–muscle-invasive bladder cancer (NMIBC). Risk categorizations in NMIBC are designated ...
Results of two phase 3 studies — IMvigor011 and DYNAMIC-III — presented at the European Society for Medical Oncology (ESMO) Annual Meeting 2025 suggest that circulating tumor DNA (ctDNA) could help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback